LuxProvide and Helical Partner to Accelerate Drug Discovery with AI & HPC

LuxProvide is proud to announce a strategic partnership with Helical, a startup company in BioTech innovation. This collaboration leverages Bio Foundation Models powered by MeluXina, bringing together High-Performance Computing (HPC), Artificial Intelligence (AI), and biology to accelerate drug discovery and pharmaceutical research.

By utilizing the immense computational power of LuxProvide’s HPC infrastructure, Helical can process vast amounts of biological data faster and more efficiently, significantly reducing the time needed for drug development. This advancement supports pharmaceutical companies in Luxembourg and beyond, enabling them to innovate at an unprecedented pace.

Strengthening the Health Tech Ecosystem

The integration of AI-driven models with supercomputing marks a transformative step in BioTech, allowing researchers to analyze complex biological structures, predict drug interactions, and optimize treatments with greater precision. This partnership is a testament to LuxProvide’s commitment to building a stronger health tech ecosystem, fostering collaboration, and driving advancements in biology.

Watch our exclusive interview with Helical to gain insights into this game-changing collaboration.